Testing and Targeting KRAS-Mutant NSCLC
Therapeutic Options in Driver-Mutation Positive mNSCLC Refractory to Frontline Small Molecular Inhibition
By
GRACE
FEATURING
Aakash Desai
By
GRACE
FEATURING
Aakash Desai
Login to view comments.
Click here to Login
Testing and Targeting KRAS-Mutant NSCLC